Hep C Test Injunction Against Abbott Reversed

Law360, New York (January 17, 2008, 12:00 AM EST) -- An appellate court on Thursday reversed part of a district court ruling in a long-standing patent dispute over hepatitis C virus testing, ruling that the lower court’s injunction barring Abbott Laboratories from selling its test was an abuse of discretion.

Additionally, although the U.S. Court of Appeals for the Federal Circuit upheld many of the district court’s rulings, finding in favor of plaintiff Innogenetics NV, the three-judge panel did reverse and remand the lower court’s judgment as a matter of law that claim 1 of the...
To view the full article, register now.